Blueberry Therapeutics have unique nanopolymer drug delivery technology which opens up huge opportunities to rapidly develop new medicines and helps us find ways to treat infection & inflammation.
Blueberry is committed to the development of innovative therapies to treat diseases where infection and inflammation are major factors.
We use cutting-edge nano polymer drug delivery technology to exploit both small molecule and biologic approaches to developing treatments.
Blueberry Therapeutics are pleased to announce they have dosed the first patient in a Phase I/II clinical trial of BB2603 [...]
David gave a presentation to Manchester Metropolitan University as part of their Biomedical Away Day. His presentation was on the [...]